Dr. Savoca brings a wealth of experience to the practice of colorectal surgery and his accomplishments are well known to all in the medical and lay communities. He has trained at some of the most prestigious medical institutions in the world including Yale University, The University of Minnesota and the National Cancer Institute. He began practice in the area in 1993. While iin Northern Virginia, Dr. Savoca has been named a Washingtonian Top Doctor every year since 2002, the first year the specialty was included in the survey. He was also named a US News and World Report Top Doctor, a Castle Connelly Top Doctor and a New York Times Super Doctor . He is a member of numerous academic societies, author of scholarly papers and books, frequent guest lecturer and legal expert often asked to render expert testimony at trial. Excellent customer service combined with the use of state of the art surgical technology along with excellent communication skills and empathy for his patients has resulted in the well-earned reputation for surgical excellence won by Dr. Savoca during his 20-plus years in practice. Dr. Savoca is proud to be associated with the premiere private multispecialty surgical group in the area - Virginia Surgery Associates. With privileges at Inova Fairfax, Inova Fair Oaks and Reston Hospitals, Dr. Savoca provides services at locations convenienty located throughout the county. Dr. Savoca provides four broad categories of treatment:
- Treatment of ano-rectal conditions
- Treatment of disorders of the large intestine
- Colonoscopy (screening for colorectal cancer)
- Evaluation/Treatment of pelvic floor disorders (bowel incontinence, constipation, pelvic prolapse)
U.S. News in partnership with Castle Connolly Medical Ltd. 2010
Savoca, Paul, MD, FACS, FASCRS, Colon and Rectal Surgeon, Fairfax, VA
U.S. News Top Doctors was developed in collaboration with Castle Connolly Medical Ltd., publisher of America's Top Doctors®. Castle Connolly bases its Top Doctors selections on nominations submitted by other doctors and is reviewed by its physician-led research team.
Dr. Savoca Highly- Rated in National Report on Surgical Complications
ProPublica, an investigative news organization that has analyzed other aspects of medical practice, posted its Surgeon Scorecard with complication rates for almost 17,000 surgeons on July 13 as reported on DC area CBS affiliates. The data are based on Medicare billing records. An accompanying new article reported that overall complication rates, based on hospital readmissions within 30 days of the surgery and death during the initial stay, ranged from 2% to 4% during the 5-year study period. Dr. Savoca was in the top five for the NoVa area. Click here to see the news article (enter zip code 22031 and click on major bowel surgery for Dr. Savoca's rating). Surgeons not on the list had average or below average ratings in comparison.
Dr. Savoca Performs First Robotic Trans-anal Excision
Robotic surgery is on the forefront of surgical innovation and Dr. Savoca has pioneered its application here in Northern Virginia. While enthusiasm for this 3D High-def version of conventional laparoscopic surgery has proven advantages in other surgical procedures, it has only recently been applied to colon and rectal surgery. The main advantage of robotics is the ability to perform precise suturing in confined spaces lending itself nicely to a procedure known as trans-anal excision. Dr. Savoca's performance of this procedure enabled a young man who had been offered radical surgery by other local colorectal surgeons, avoid a permanent colostomy without any external incision. Watch Video
New Treatments for Bowel Incontinence
Two recently FDA approved revolutionary treatments for bowel incontinence are now available. Solesta is an injectable gel that bulks the anal sphincter and SNS (sacral nerve stimulation) is a procedure where continuous low energy electrical impulses delivered into the anal sphincter strengthen this muscle painlessly. Both treatments represent significant advances in this under-treated disorder which affects women almost exclusively, offering hope for an embarrassing condition in a minimally invasive way.